Long-term follow up of diabetic patients treated with sirolimus-eluting stents. An angiographic and three-dimensional intravascular ultrasound study

Journal of Invasive Cardiology

Volumn 18, Issue 4, 2006, Pages 142-146

  Vaz, Vinicius D ^a   Abizaid, Alexandre ^a   Chaves, Aurea ^a   Feres, Fausto ^a   Ferreira, Eduardo ^a   Mattos, Luiz ^a   Staico, Rodolfo ^a   Abizaid, Andrea ^a   Tanajura, Luiz ^a   Centemero, Marinella ^a   Mintz, Gary ^b   Sousa, Amanda ^a   Sousa, J Eduardo ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Diabetes mellitus; Follow up studies; Stents; Ultrasonic

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CATCH UP PHENOMENON; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; RESTENOSIS; THREE DIMENSIONAL IMAGING; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; CORONARY ARTERY ATHEROSCLEROSIS; ENDOSCOPIC ECHOGRAPHY; MIDDLE AGED; STENT;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; SIROLIMUS; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33745115665     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Carrozza JP Jr, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993;118:344-349.
2. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
3. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-640.
4. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-1873.
5. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589.
6. Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002;40:410-417.
7. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-195.
8. Moses JW, Leon MB, Popma JJ, et al. for the SIRIUS Investigators. Sirolimus-eluting stent versus standard stents in patients with stenosis in native coronary artery. N Engl J Med 2003;349:1315-1323.
9. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world". The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 2004;109:190-195.
10. Morice MC, Serruys PW, Sousa JE, et al. for the RAVEL Study Group. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780
11. Hoye A, Tanabe K, Lemos PA, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004;43:1954-1958
12. Saia F, Lemos PA, Lee CH, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: A clinical and angiographic study. Circulation 2003;108:1927-1929
13. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2002;207:24-27.
14. Davi G, Catalano I, Averna M, et al. Thomboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl Med 1990;322:1769-1774.
15. Betteridge DJ. Diabetic dyslipidemia. Am J Med. 1994; 96:25S-31S.
16. Carmassi F, Morale M, Puccetti R, et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 1992;67:634-654.
17. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium- dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-2516.
18. Ostermam H, van de Loo J. Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Haemostasis 1986;16:386-416.
19. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27:528-535.
20. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997;95:1366-1369.
21. Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002;40:410-417.
22. Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986-2991.
23. Kiemeneij F, Serruys PW, Macaya C, et al. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of BENESTENT-I trial. J Am Coll Cardiol 2001;37:1598-1603.
24. Hong MK, Mintz GS, Lee CW, et al. Late intravascular ultrasound findings of patients treated with brachytherapy for diffuse in-stent restenosis. Catheter Cardiovasc Interv 2004;63:208-214.
25. Feres F, Muñoz JS, Abizaid A, et al. In-stent restenosis: Is there a difference in the late outcomes between brachytherapy and sirolimus-eluting stent implantation? (Abstr). Am J Cardiol 2003;(Suppl 9)2:89.
26. Abizaid A, Costa MA, Blanchard D, et al. for the RAVEL Investigators. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial. Eur Heart J 2004;25:107-112.
27. Sousa JE, Costa MA, Abizaid A, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 2005;111:2326-2329.
28. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents. One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-2011.
29. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381-383.
30. Takagi T, Akasaka T, Yamamuro A, et al. Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study. J Am Coll Cardiol 2000;36:1529-1535.
31. Chaves AJ, Sousa AG, Mattos LA, et al. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab. Results of the Diabetes Abciximab steNT Evaluation (DANTE) Randomized Trial. Circulation 2004;109:861-866.
32. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stent on outcome in diabetic patients. A SIRIUS (SIRolImUS-eluting Bx velocity balloon expandable in the treatment of patients with de novo coronary artery lesions) Substudy. Circulation 2004;109:101-106.